Columbus McKinnon (NASDAQ:CMCO) is scheduled to report fourth-quarter earnings on Monday, February 12, 2026. Last quarter, the company posted revenue of $261 million, 8.5% above analyst expectations and 7.7% year-on-year. It outperformed on EBITDA and revenue guidance. For this quarter, analysts expect revenue to grow 4.9% year-on-year to $245.7 million, and adjusted earnings of $0.58 per share. Columbus has missed Wall Street revenue estimates five times in the past two years. Peer performance in general industrial machinery is mixed: GE Aerospace revenue rose 17.6% and fell 7.7% post-results; Crane revenue up 6.8% and shares down 11.5%. Columbus is up 13.4% in the past month while the average analyst price target is $26.75 versus its current price of $22.88.

Dynatrace (NYSE:DT) will report earnings Monday, February 8, 2026, before the bell. Last quarter, the company beat revenue expectations by 1.3% to $493.8M, up 18.1% YoY, surpassed EBITDA guidance, but missed billings. For this quarter, analysts expect revenue of $505.9M, up 16% YoY, and adjusted EPS of $0.41/share. The average price target is $57.23, versus the current share price of $33.73. Dynatrace has beaten revenue estimates in each of the past two years by about 2.1% on average. In the software development sector, only F5 has reported so far, outperforming with 8.8% revenue beat and 7.3% YoY sales growth, while software development peers are down 18.7% in the last month and Dynatrace is down 20.3%.

Corebridge Financial (NYSE:CRBG) will report earnings after the market close on Monday, February 10, 2026. Last quarter, the company beat revenue expectations by 49.7%, recording $5.63 billion, up 34.2% YoY, but missed EPS by a significant margin. For the current quarter, analysts expect revenue to decline 7.9% YoY to $4.31 billion, up from a 21.1% drop in the same quarter last year, with adjusted earnings at $1.11 per share. The average analyst price target is $37.69 versus the current share price of $31.16. Over the past two years, Corebridge has missed revenue estimates five times.

Cincinnati Financial (NASDAQ:CINF) is scheduled to report after-market close on February 13, 2026. Last quarter, the insurer delivered $2.87B in revenue, up 12.1% YoY, and adjusted EPS of $10.28 beat expectations. For Q4 2025, revenue is expected to rise 10.1% YoY to $2.92B and adjusted EPS to $2.89/share. Analysts have maintained their estimates recently, while P&C peers posted growth: Stewart Information Services +19.6% YoY and Allstate +3.4% YoY. Cincinnati Financial’s shares are unchanged over the past month; the average analyst price target is $174.80 versus the current $161.00.

Butterfield Bank (NYSE:NTB) reports earnings Monday after market close. Fourth-quarter revenue is expected to rise 1.1% year on year to $153.5 million, down from 3.4% in the same quarter of 2024, and adjusted EPS is forecast at $1.47 per share. The company outperformed in Q3, recording $153.9 million in revenue, up 6.8% YoY, and beating both revenue and earnings estimates by average margins of 3.3% over the past two years. Peer performance in regional banking is mixed; Merchants Bancorp revenue fell 4.4% YoY but beat estimates by 7.8%, while UMB Financial posted a 67.5% year-on-year increase and topped estimates by 7%. Regional bank shares averaged up 7.9% in the past month, while NTB is up 5.5% and trades at $53.06 versus an average analyst price target of $50.67.

Becton, Dickinson and Company (NYSE:BDX) will report results Monday before the bell. Last quarter, the medical technology company posted revenue of $5.89 billion, up 8.3% year-on-year, and narrowly beat EPS estimates despite revenue in line with expectations.

This quarter, analysts expect revenue to be flat year-on-year at $5.15 billion, down from a 9.8% increase in the same quarter last year, with adjusted earnings at $2.81 per share. Over the past 30 days, analyst estimates have remained stable, though the company has missed revenue guidance four times in the past two years.

In the healthcare equipment and supplies sector, STERIS and CONMED posted revenue gains of 9.2% and 7.9%, respectively, outperforming estimates. STERIS shares fell 7.7% and CONMED 3.6% on results. BDX is up 3.6% over the last month, trading at $206.89 with an average analyst price target of $211.92.

Amkor Technology (NASDAQ:AMKR) is scheduled to report results on February 15, 2026, following market close. Last quarter, the company posted revenue of $1.99 billion, up 6.7% YoY, and beat EPS estimates, outperforming revenue guidance by 2.6%. For Q4 2025, analysts expect revenue to rise 12.5% YoY to $1.83 billion and adjusted EPS of $0.44 per share. Amkor has exceeded Wall Street’s revenue expectations by an average of 2% over the past two years and is expected to miss its guidance this quarter.

Peer context indicates strength in the segment: Teradyne (TD) revenue rose 43.9% YoY, outpacing estimates by 11%, and Kulicke & Soffa (KULI) revenue increased 20.2% YoY, beating estimates by 5%. Teradyne gained 13.4% and Kulicke & Soffa 19.3% on respective earnings releases. Amkor is down 5.4% over the past month while the sector averaged +9.6% and has an average analyst price target of $44.75 versus its current share price of $49.49.

[Para 1: The Lead]

As AI-driven volatility reemerges, analysts caution against chasing tech-sector selloffs and recommend pausing and favoring more resilient sectors until the tech leg of the market stabilizes.

[Para 2: Supporting Details & Context]

The S&P 500 rose over 1% on Feb 6 after a 1% decline on Feb 5, while the Nasdaq Composite fell about 1% amid weakness in Microsoft (MSFT-US) and NVIDIA (NVDA-US). The VIX climbed but remains below its April 2023 high. Concerns over disruptive AI tools, such as Anthropic’s Claude Opus 4.6, have heightened sell-offs in software, consulting, data analytics, and legal services.

[Para 3: Sector Insights]

Non-tech sectors outperformed: energy up 21% YTD, materials, industrials, and consumer staples gained; utilities were the only non-tech laggard (-4% YTD). Despite strong underlying profits, tech remains the大盘’s largest weight, and its continued weakness could pressure broader indices. For alternatives, consider JPMorgan Chase (JPM-US), TSMC (2330-TW), and small-cap value, including KO (KO-US) and GM (GM-US). The SPDR S&P SmallCap 600 (RSP-US) offers broad diversification with no single stock exceeding 0.25% of the index weight.]

Goldman Sachs (GS:US) is collaborating with AI startup Anthropic to develop Claude-based AI co-pilots that automate accounting, compliance, and due diligence workflows.

Marco Argenti, Goldman Sachs’ head of information, confirmed Anthropic engineers have been on-site for six months building autonomous agents to handle back-office tasks such as trade accounting, client onboarding, and AML screenings. The initiative is in its early stages, with a planned rollout of these agents expected soon, though no specific timeline was provided.

Anthropic’s Claude Cowork platform, designed to assist白领 workers with computer-related tasks, is being leveraged for this effort. Goldman Sachs aims to boost operational efficiency and reduce reliance on expanding headcount, with high-level executives noting surprise at AI’s success in structured, non-programming domains like accounting and compliance.

Hims & Hers (HIMS) has canceled plans to sell a compounded version of Novo Nordisk’s (NVO) GLP-1 weight-loss pill following FDA warnings and a potential DOJ investigation. In a Saturday X post, the company stated it stopped offering access after “constructive conversations” with industry stakeholders. The move ends a recent plan to launch an oral compounded form of Wegovy, following legal threats from Novo and rapid regulatory pressure. The FDA had earlier warned of restricting active ingredients used in similar alternatives to approved medications, and HIMS was referred to the Department of Justice. The decision follows a recent approval of Wegovy in pill form, which has driven early strong prescriptions for Novo despite competition from compounded generics and pricing pressure.

February 7, 2026 — Following a sharp decline to $60,000 by February 5, 2026, bitcoin is witnessing broad-based accumulation across wallet cohorts. Glassnode’s Accumulation Trend Score by cohort rose to 0.68, the first time since late November it has exceeded 0.5. A score near 1 indicates accumulation; near 0 indicates distribution. Wallets holding 10–100 BTC have been the most aggressive buyers as prices approached $60,000. With over 50% retracement from the October all-time high, the pattern mirrors past bottom formations near $80,000.

Hims & Hers (HIMS) announced it is ceasing to offer a compounded knockoff of Novo Nordisk’s Wegovy (semaglutide) injection, effective Saturday, Feb 7, 2026. The move follows the FDA’s Feb 5 threat to limit access to active ingredients in GLP-1 weight-loss drugs, prompting Novo to sue and prompting HIMS to halt its planned offering. The company had planned to sell the compounded pill for $49/month in the first month, down from $149 for Novo’s approved version.

HIMS’ website reflected the change hours after the announcement. The decision does not affect its existing compounded injectables, which are sold under an exception allowing personalized prescriptions. Novo is scheduled to promote the new Wegovy in a Super Bowl ad Sunday.

Block (BKY) is considering cutting up to 10% of its workforce during annual performance reviews, according to a Bloomberg News report dated February 7, 2026, citing sources familiar with the matter. The report notes the company is weighing significant reductions amid ongoing performance challenges. Reuters could not immediately verify the details of the proposed layoffs.

Creditors Apollo Capital Management, BlackRock Financial Management, and Oaktree Capital Management have moved to dismiss Optimum Communications Inc.’s (NMS: OCOM) (OTC: OCOMF) antitrust lawsuit, arguing the company is using federal law to block creditor cooperation in restructurings. The New York federal court filing contends that U.S. antitrust rules do not apply to creditor collusion in debt workouts and that Altice seeks to weaponize such laws to gain leverage in renegotiations.

The lenders allege Altice is attempting to rewrite credit contracts by citing cooperation agreements among creditors, which are designed to negotiate as a bloc for greater leverage. The motion seeks dismissal of the November filing, which alleges violations of federal law by pacts meant to limit competition among creditors.

Altice, now Optimum Communications Inc., is in financial distress under heavy debt and is seeking legal advice to prepare for a potential restructuring, according to a court filing and a statement from White & Case, the firm it hired to advise on its recapitalization.

U.S. debt-servicing costs exceed $1 trillion annually, with interest payments alone surpassing the military budget and outpacing spending on Medicare, according to Tesla CEO Elon Musk in a February 7, 2026 interview with Dwarkesh Patel.

Musk warned the country is “1,000% going to go bankrupt” without large-scale AI and robotics adoption to boost productivity, arguing only such transformative growth can address the $38.5 trillion national debt. He cautioned that faster output without a commensurate expansion of the money supply could lead to deflation,加重 real debt burdens.

While the U.S. benefits from its reserve-currency地位, the Committee for a Responsible Federal Budget warned last month that without policy correction, multiple fiscal crises are almost inevitable.

Coca-Cola (KO) will discontinue its frozen beverage line by April 2026, citing shifting consumer preferences and declining sales. The decision follows a 12-month review of its portfolio, with the frozen line contributing less than 1% of annual sales. The company will phase out the products by the end of 2026, with affected items including its popular Mountain Dew and Celsius flavors in frozen formats. The move reflects a broader realignment toward healthier, non-sugary options and reflects the segment's poor performance in a warming market.

Google is planning a broader rollout of its AirDrop-style file-sharing capabilities across Android devices, according to internal signals reviewed by analysts. The update, tentatively scheduled for Q1 2026, aims to enhance cross-device productivity by allowing users to share photos, documents, and other files with nearby devices. The move follows a successful initial release in select regions and is expected to impact shares of companies like Motorola Solutions and Garmin, which rely on Android and wearable ecosystems.

Tesla announced it is exploring the leasing of manufacturing sites within the United States to accelerate the domestic production of solar cells, aiming to reduce supply chain risks and enhance energy independence. The company plans to finalize potential locations by April 2026, with a projected start of production in the second half of 2026. The initiative follows the pending completion of its acquisition of Sunrun, which is expected to close in Q3 2026, and is part of Tesla’s broader strategy to expand its renewable energy offerings. Financial terms of the proposed facility leases have not been disclosed.

Cardano (ADA) co-founder Charles Hoskinson (CHHS) disclosed an estimated $3 billion in unrealized losses during the recent crypto rout, reflecting the broader selloff from February 1, 2026, through February 7, 2026. Bitcoin fell to about $60,000, a 16% drop, and the CoinDesk 20 index declined 17%, while ADA dropped 15.6% in the week. Hoskinson said he maintains long-term positions and has no immediate plans to liquidate, framing the decline as a transition period for the evolving financial technology ecosystem.

Bitcoin’s 2/7/26 nearly 50% plunge is attributed by veteran Gary Bode to inherent volatility, not a systemic crisis. While 80%–90% drawdowns are common in crypto, the recent selloff was amplified by perceptions of a hawkish Fed and margin calls from leveraged positions.

Bode disputes interpretations of Fed Chair nominee Kevin Warsh and highlights statements supporting lower rates, alongside U.S. deficits and the Fed’s limited influence on longer-term Treasuries. He views “whale” sales as profit-taking, not bearish signals, noting that paper BTC (ETFs, derivatives) increase trading supply without affecting the 21 million coin cap.

He warns of short-term pressure on Strategy (MSTR) as BTC dipped below purchase levels but emphasizes bitcoin’s resilience. Bode argues energy cost concerns and potential hash rate declines are overblown, citing historical lags and emerging low-cost energy solutions.

In conclusion, Bode frames volatility as part of bitcoin’s design and a temporary phase; long-term value remains anchored by the capped supply and its permissionless, counterparty-free nature.